- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 26 Jul 23 EFFECT Notice of effectiveness
- 24 Jul 23 POS AM Prospectus update (post-effective amendment)
- 26 Sep 22 424B3 Prospectus supplement
- 15 Aug 22 424B3 Prospectus supplement
- 1 Jun 22 424B3 Prospectus supplement
- 18 May 22 424B3 Prospectus supplement
- 7 Apr 22 424B3 Prospectus supplement
- 7 Apr 22 EFFECT Notice of effectiveness
- 5 Apr 22 POS AM Prospectus update (post-effective amendment)
- 17 Mar 22 424B3 Prospectus supplement
- 15 Feb 22 424B3 Prospectus supplement
- 15 Feb 22 EFFECT Notice of effectiveness
-
7 Feb 22 S-1 IPO registration
Exhibit 16.1
February 7, 2022
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Ladies and Gentlemen:
We have read GreenLight Biosciences Holding, PBC’s (formerly known as Environmental Impact Acquisition Corp.) statements included under Item 4.01 of its Form 8-K dated February 2, 2022. We agree with the statements concerning our Firm under Item 4.01, in which we were informed of our dismissal on February 7, 2022, following completion of the Company’s annual audit for the year ended December 31, 2021, which consists only of the accounts of the pre-Business Combination Special Purpose Acquisition Company. We are not in a position to agree or disagree with other statements contained therein.
Very truly yours, |
/s/ WithumSmith+Brown, PC |
New York, New York |